Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

Saved in:

Bibliographic Details
Main Authors:	Chenghao Fu, Haonan Du, Qiang Wang, Weiyou Zhu, Guangli Bian, Zhujuan Zhong, Yuheng Wang, Lei Cao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Immunology
Subjects:	tail effect immunotherapy cancer therapy PSC ICI Sintilimab
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1527232/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib
by: Chenghao Fu, et al.
Published: (2024-11-01)

Pig tail length is associated with the prevalence of tail malformations but not with inflammation of the tail
by: Christiane Egerer, et al.
Published: (2025-02-01)

Evaluation of the efficacy and safety of TACE combined with anlotinib and sintilimab in the treatment of patient with CNLC stage ⅡB-ⅢB liver cancer
by: TONG Gang, HUA Yang, PENG Wei, ZHAO Ju, HU Junwen
Published: (2025-05-01)

Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
by: Jiaxiang Ji, et al.
Published: (2024-12-01)

Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer
by: Jing Liu, et al.
Published: (2025-07-01)

Combination therapy of TKIs and ICIs for the treatment of anaplastic thyroid carcinoma
by: Xi Zhang, et al.
Published: (2025-05-01)

The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma
by: Chenglong Zhao, et al.
Published: (2025-06-01)

Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial
by: Tianqing Chu, et al.
Published: (2025-04-01)

Hyperprogression disease induced by Sintilimab combined with Oxaliplatin and S-1 after surgery: a case report and literature review
by: Yaoqi Li, et al.
Published: (2025-06-01)

A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1
by: Pei Zhu, et al.
Published: (2025-02-01)

Case Report: Multiple cutaneous keratoacanthoma-like lesions in a colorectal cancer patient treated with sintilimab
by: Shiyi Li, et al.
Published: (2025-03-01)

White-tailed Deer of Florida
by: Raoul K Boughton, et al.
Published: (2020-04-01)

White-tailed Deer of Florida
by: Raoul K Boughton, et al.
Published: (2020-04-01)

Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab
by: Chang-Fu Liu, et al.
Published: (2025-08-01)

Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report
by: Ming-xing Wang, et al.
Published: (2025-01-01)

Severe thyroiditis induced by sintilimab monotherapy in a patient with non-small cell lung cancer: a case report and literature review
by: Xiaolin Zhao, et al.
Published: (2025-02-01)

Distribution and moment characteristics of a quotient of heavy-tailed random variables
by: Kęstutis Gadeikis
Published: (2023-09-01)

CONSIDERATIONS FOR BRITTLENESS IN TAILINGS
by: Jiří Herza, et al.
Published: (2022-01-01)

Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial
by: Jincheng Guo, et al.
Published: (2025-04-01)

Case Report: Successful treatment of triple primary cancers (lung, stomach, and intestine) using sintilimab combined with chemotherapy and targeted therapy
by: Qi-Qing Zhang, et al.
Published: (2025-08-01)

Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review
by: Genlin Lu, et al.
Published: (2025-01-01)

Stevens–Johnson syndrome induced by Sintilimab: a case report and literature review
by: Huan Kuang, et al.
Published: (2025-05-01)

Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China
by: Lei Mao, et al.
Published: (2025-06-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)

Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report
by: Chenxi Zhang, et al.
Published: (2025-04-01)

Genome-Wide Association Study Reveals Single Nucleotide Polymorphisms Associated with Tail Length and Tail Kinks in Piglets
by: Katharina Gerhards, et al.
Published: (2025-02-01)

Applying Model-Based Systems Engineering to Tailings Storage Facility Structures
by: Bartłomiej Bursa, et al.
Published: (2023-10-01)

Severe immune-mediated myocarditis caused by sintilimab combined with gemcitabine: a case report and literature review
by: Haixia Yang, et al.
Published: (2025-04-01)

Sintilimab-induced intestinal obstruction and hemorrhage of the digestive tract: a case report
by: Qian Hao, et al.
Published: (2025-07-01)

Highly tail-asymmetric lipids interdigitate and cause bidirectional ordering
by: Tugba N. Ozturk, et al.
Published: (2025-05-01)

Fruquintinib and sintilimab plus SOX as perioperative therapy for locally resectable advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase II clinical trial
by: Xiangyu Meng, et al.
Published: (2025-07-01)

Case Report: A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer
by: Peipei Mou, et al.
Published: (2025-04-01)

Cost-effectiveness analysis of sintilimab additional to chemoradiotherapy in high-risk locoregionally advanced nasopharyngeal carcinoma
by: Longjiang She, et al.
Published: (2025-07-01)

Lumpy Jaw in White-tailed Deer
by: Juan Manuel Campos Krauer, et al.
Published: (2020-10-01)

Experimental Study on Factors Affecting Waterproof Failure of Shield Tail Sealing System
by: JIANG Peifeng
Published: (2025-04-01)

Study of Cooling Characteristics of Axisymmetric Tail Nozzle
by: Hao Zeng, et al.
Published: (2024-12-01)

Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinoma
by: Kunyuan Wang, et al.
Published: (2025-06-01)

Multimodal Framework for Long-Tailed Recognition
by: Jian Chen, et al.
Published: (2024-11-01)

Successful treatment with sintilimab for SMARCA4-deficient non-small cell lung carcinoma: two case reports
by: Liwen Wang, et al.
Published: (2025-07-01)

Reweighting balanced representation learning for long tailed image recognition in multiple domains
by: Panpan Fu, et al.
Published: (2025-07-01)